SCHEMBL4256946

SCHEMBL4256946

CCOC(=O)c1c(-c2ccc(NC(=O)O)cc2)csc1N1C(=O)c2ccccc2C1=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.56
PRKCZ Q05513 1/20 0.53
HTT P42858 2/20 0.52
TP53 P04637 1/20 0.52
LMNA P02545 8/20 0.52
HPGD P15428 5/20 0.52
MAPT P10636 4/20 0.52
CYP1A2 P05177 2/20 0.52
CYP2C9 P11712 2/20 0.52
CYP2C19 P33261 2/20 0.52
CYP3A4 P08684 1/20 0.52
SMN1; SMN2 Q16637 6/20 0.51
POLB P06746 1/20 0.50
RAB9A P51151 1/20 0.50
PTPN1 P18031 2/20 0.49
PTPRC P08575 1/20 0.49
PTPRF P10586 1/20 0.49
PTPN2 P17706 1/20 0.49
PTPA Q15257 1/20 0.49
GSTO1 P78417 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1554259 0.90 ALDH1A1 (0.60) ALDH1A1PRKCZHTTTP53LMNA
SCHEMBL1553441 0.89 ALDH1A1 (0.52) ALDH1A1PRKCZHTTTP53LMNA
SCHEMBL1553883 0.89 ALDH1A1 (0.55) ALDH1A1PRKCZHTTTP53LMNA
SCHEMBL4252376 0.89 ALDH1A1 (0.53) ALDH1A1HTTTP53LMNAHPGD
SCHEMBL1554609 0.88 ALDH1A1 (0.49) ALDH1A1PRKCZHTTTP53LMNA
SCHEMBL1553140 0.86 TP53 (0.53) ALDH1A1PRKCZHTTTP53LMNA
SCHEMBL1554407 0.86 PRKCZ (0.61) ALDH1A1PRKCZHTTTP53LMNA
SCHEMBL4563209 0.86 KMT2A (0.42) ALDH1A1HTTTP53LMNAMAPT
SCHEMBL1554640 0.85 ALDH1A1 (0.63) ALDH1A1PRKCZHTTTP53LMNA
SCHEMBL4254043 0.85 ALDH1A1 (0.50) ALDH1A1HTTTP53LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1383463-A4 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE KING PHARMACEUTICALS INC (US) 2009-03-25 EP disclosed
EP-1383463-A2 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE King Pharmaceuticals, Inc. (US) 2004-01-28 EP disclosed
WO-2002083083-A2 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE KING PHARMACEUTICALS, INC. (US) 2002-10-24 WO disclosed